Aneta Rogalska

22PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 13, 2026
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.

|May 27, 2026
Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?

|Mar 28, 2026
Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer.

Patrycja Gralewska-Zając, Aleksandra Przybylska, Marek Langner

|Jan 25, 2025
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.

Wiktoria Bębenek, Arkadiusz Gajek, Agnieszka Marczak

|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines.

Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek

|Nov 27, 2024
Folate Receptor Alpha-A Secret Weapon in Ovarian Cancer Treatment?

Karol Bukowski, Aneta Rogalska, Agnieszka Marczak

Pageof 4

Frequent Collaborators

14 joint publications

Agnieszka Marczak

8 joint publications

Arkadiusz Gajek

7 joint publications

Patrycja Gralewska-Zając

4 joint publications

Agnieszka Śliwińska